Citizens & Northern Corp reduced its stake in shares of The Procter & Gamble Company (NYSE:PG – Free Report) by 4.0% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 18,706 shares of the company’s stock after selling 782 shares during the period. Procter & Gamble accounts for about 1.0% of Citizens & Northern Corp’s holdings, making the stock its 21st biggest position. Citizens & Northern Corp’s holdings in Procter & Gamble were worth $2,741,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
A number of other institutional investors and hedge funds have also recently bought and sold shares of PG. WealthPlan Investment Management LLC boosted its stake in Procter & Gamble by 420.4% in the 3rd quarter. WealthPlan Investment Management LLC now owns 4,829 shares of the company’s stock worth $704,000 after buying an additional 3,901 shares during the last quarter. OVERSEA CHINESE BANKING Corp Ltd purchased a new position in Procter & Gamble during the third quarter worth approximately $513,000. Bahl & Gaynor Inc. boosted its holdings in shares of Procter & Gamble by 2.1% in the 3rd quarter. Bahl & Gaynor Inc. now owns 4,292,406 shares of the company’s stock valued at $626,090,000 after purchasing an additional 90,154 shares during the last quarter. Stack Financial Management Inc increased its holdings in shares of Procter & Gamble by 0.3% during the 3rd quarter. Stack Financial Management Inc now owns 98,689 shares of the company’s stock worth $14,395,000 after buying an additional 262 shares during the last quarter. Finally, Certuity LLC raised its position in shares of Procter & Gamble by 28.0% in the 3rd quarter. Certuity LLC now owns 8,591 shares of the company’s stock worth $1,253,000 after buying an additional 1,877 shares during the period. Hedge funds and other institutional investors own 65.77% of the company’s stock.
Procter & Gamble Stock Down 1.2 %
Procter & Gamble stock traded down $2.07 during mid-day trading on Thursday, hitting $165.74. The company’s stock had a trading volume of 2,866,542 shares, compared to its average volume of 6,655,700. The company has a debt-to-equity ratio of 0.49, a current ratio of 0.69 and a quick ratio of 0.48. The Procter & Gamble Company has a 52-week low of $141.45 and a 52-week high of $168.54. The firm’s 50 day moving average is $161.67 and its 200 day moving average is $155.78. The company has a market cap of $391.17 billion, a PE ratio of 27.41, a price-to-earnings-growth ratio of 3.42 and a beta of 0.43.
Procter & Gamble Increases Dividend
The firm also recently declared a quarterly dividend, which was paid on Wednesday, May 15th. Stockholders of record on Friday, April 19th were issued a dividend of $1.0065 per share. The ex-dividend date was Thursday, April 18th. This represents a $4.03 dividend on an annualized basis and a dividend yield of 2.43%. This is an increase from Procter & Gamble’s previous quarterly dividend of $0.94. Procter & Gamble’s dividend payout ratio (DPR) is currently 65.85%.
Analyst Upgrades and Downgrades
Several equities research analysts recently commented on PG shares. Wells Fargo & Company raised their target price on Procter & Gamble from $162.00 to $170.00 and gave the company an “overweight” rating in a report on Wednesday, January 24th. StockNews.com lowered shares of Procter & Gamble from a “buy” rating to a “hold” rating in a report on Thursday, February 29th. Stifel Nicolaus raised their target price on Procter & Gamble from $155.00 to $157.00 and gave the company a “hold” rating in a research note on Wednesday, January 24th. Argus boosted their price target on Procter & Gamble from $180.00 to $185.00 and gave the stock a “buy” rating in a research note on Thursday, April 25th. Finally, Deutsche Bank Aktiengesellschaft cut their target price on Procter & Gamble from $172.00 to $171.00 and set a “buy” rating on the stock in a research report on Monday, April 22nd. Seven equities research analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the company’s stock. According to MarketBeat.com, Procter & Gamble presently has a consensus rating of “Moderate Buy” and a consensus price target of $169.76.
View Our Latest Stock Analysis on Procter & Gamble
Insider Buying and Selling
In related news, CEO R. Alexandra Keith sold 776 shares of the business’s stock in a transaction that occurred on Monday, March 4th. The stock was sold at an average price of $158.11, for a total value of $122,693.36. Following the completion of the sale, the chief executive officer now directly owns 4,859 shares in the company, valued at approximately $768,256.49. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. In related news, CEO R. Alexandra Keith sold 776 shares of the stock in a transaction that occurred on Monday, March 4th. The stock was sold at an average price of $158.11, for a total transaction of $122,693.36. Following the completion of the sale, the chief executive officer now owns 4,859 shares in the company, valued at approximately $768,256.49. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, CEO Sundar G. Raman sold 31,924 shares of the company’s stock in a transaction that occurred on Monday, May 20th. The stock was sold at an average price of $166.95, for a total value of $5,329,711.80. Following the transaction, the chief executive officer now owns 19,042 shares of the company’s stock, valued at $3,179,061.90. The disclosure for this sale can be found here. Over the last three months, insiders sold 181,185 shares of company stock worth $29,705,503. Corporate insiders own 0.17% of the company’s stock.
Procter & Gamble Company Profile
The Procter & Gamble Company provides branded consumer packaged goods worldwide. It operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, and SK-II brands.
Featured Articles
- Five stocks we like better than Procter & Gamble
- Most Volatile Stocks, What Investors Need to Know
- What is a Short Call Butterfly Spread? Explanation with Examples
- Do ETFs Pay Dividends? What You Need to Know
- First Quarter Wrap-Up Reveals Retail’s Shifting Sands
- Consumer Discretionary Stocks Explained
- Williams-Sonoma Stock Forecast to Hit $500? Here’s How
Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.